Intact circadian rhythm despite cortisol hypersecretion in Alzheimer's disease: A meta-analysis
Ursula G Saelzler1, Paul Verhaeghen2, Matthew S Panizzon1
1Department of Psychiatry, University of California San Diego, 9500 Gilman Dr. La Jolla, San Diego, CA 92093, USA.
Psychoneuroendocrinology
|August 2, 2021
Summary
Individuals with Alzheimer's disease (AD) exhibit elevated basal cortisol levels, but their cortisol circadian rhythm remains intact. This meta-analysis confirms cortisol hypersecretion in AD, suggesting hippocampal deterioration impacts the HPA axis.
Area of Science:
- Neuroendocrinology
- Geriatric Medicine
- Molecular Psychiatry
Background:
- Hypersecretion of cortisol, a glucocorticoid hormone, is a long-suspected phenomenon in Alzheimer's disease (AD).
- Decades of research have explored the link between AD and cortisol levels, necessitating a comprehensive review.
Purpose of the Study:
- To systematically review and meta-analyze existing literature on cortisol levels in individuals with AD.
- To determine if participant and methodological factors influence cortisol hypersecretion in AD.
- To assess the integrity of the cortisol circadian rhythm in individuals with AD.
Main Methods:
- A meta-analysis and systematic review of over 300 comparisons of hypothalamic-pituitary-adrenal (HPA) axis functioning.
- Comparison of basal cortisol indices between individuals with AD and cognitively normal older adults.
- Analysis of participant characteristics and time-of-day sampling for effect modification.
Main Results:
- A significant association between AD and basal cortisol elevations (g = 0.45) was found.
- No systematic impact of participant characteristics or sampling time on cortisol hypersecretion magnitude was observed.
- No evidence of group differences in direct indices of cortisol circadian rhythmicity, including the cortisol awakening response and diurnal slope.
Conclusions:
- Basal hypersecretion of cortisol, not circadian dysrhythmia, characterizes individuals with Alzheimer's disease.
- Observed hypersecretion aligns with theories of AD-induced hippocampal deterioration and reduced HPA axis inhibition.
- Further research is needed to clarify the role and timing of cortisol elevations in AD progression.
Related Concept Videos
Circadian Rhythms and Gene Regulation
4.2K
The biological clock is involved in many aspects of regulating complex physiology in all animals. It was in 1935 when German zoologists, Hans Kalmus and Erwin Bünning, discovered the existence of circadian rhythm in Drosophila melanogaster. However, the internal molecular mechanisms behind the circadian clock remained a mystery until 1984, when Jeffrey C. Hall, Michael Rosbash, and Michael W. Young discovered the expression of the Per gene oscillating over a 24-hour cycle. In subsequent...
4.2K
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
171
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
171
Alzheimer's Disease: Overview
877
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
877
Alzheimer's Disease: Treatment
416
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
416
Sleep-Wake Cycles
1.9K
Sleep is an essential physiological process vital to maintaining overall well-being. The reticular activating system (RAS), a network of neurons in the brainstem, regulates wakefulness and sleep. While it may seem passive, sleep consists of distinct cycles, each with its unique characteristics and functions. Two key sleep phases are non-rapid eye movement (NREM) and rapid eye movement (REM).
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
1.9K
Aging
356
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
356


